Keyphrases
Myopic Choroidal Neovascularization (mCNV)
100%
Age-related Macular Degeneration
100%
Somatostatin
100%
Somatostatin Receptor 2 (SSTR2)
100%
Age-related Maculopathy
100%
Somatostatin Receptor Subtypes
100%
Normal Human
75%
Somatostatin Analogs
75%
Growth Factors
50%
Choroidal
50%
Choroidal Neovascular Membrane
50%
Posterior Pole
50%
Neovascular
50%
Human Macula
50%
MRNA Expression
25%
Immunohistochemistry
25%
Quantitative PCR
25%
Donor Eyes
25%
Human Eye
25%
Angiogenesis
25%
Effective Therapy
25%
Octreotide
25%
Growth Hormone
25%
Insulin-like
25%
Somatostatin Receptor 4
25%
Effects on Humans
25%
Cell-like
25%
Ocular Neovascularization
25%
Antiangiogenic
25%
Human Retinal Endothelial Cells
25%
Paraffin Embedding
25%
Fibroblast-like
25%
Formaldehyde
25%
Immunohistochemical Expression
25%
Antiproliferative Activity
25%
Antiangiogenic Activity
25%
Fibrovascular
25%
Medicine and Dentistry
Choroidal Neovascularization
100%
Age Related Macular Degeneration
100%
Somatostatin Receptor
100%
Receptor Subtype
83%
Maculopathy
66%
Somatostatin
66%
Somatostatin Derivative
50%
Endothelial Cell
33%
Choroidal Neovascular Membrane
33%
Posterior Pole
33%
Fibroblast
16%
Immunohistochemistry
16%
Growth Factor
16%
Angiogenesis
16%
Octreotide
16%
Growth Hormone
16%
Enucleation of the Eye
16%
Somatomedin
16%
Antiproliferative Activity
16%
Antiangiogenic Activity
16%
Reverse Transcription Polymerase Chain Reaction
16%
Antiangiogenic
16%
Neuroscience
Age-Related Macular Degeneration
100%
Somatostatin Receptor
100%
Choroidal Neovascularization
100%
Receptor Subtype
83%
Maculopathy
66%
Somatostatin
66%
Somatostatin Derivative
50%
Choroidal Neovascular Membrane
33%
Immunohistochemistry
16%
Octreotide
16%
Angiogenesis
16%
Bovine Somatotropin
16%
Growth Hormone Treatment
16%
Fibroblast
16%
Growth Factor
16%
Somatomedin
16%
Reverse Transcription Polymerase Chain Reaction
16%
Veterinary Science and Veterinary Medicine
Somatostatin
100%
Growth Factor
7%
Fibroblast
7%
Octreotide
7%
Bovine Somatotropin
7%
Growth Hormone Treatment
7%
Somatomedin
7%